Hitachi, Ltd. and Taiwan Hitachi Asia Pacific Co., Ltd. have agreed to establish a joint venture company for the manufacture and sales of cells used in regenerative medicine, in collaboration with multiple funds and influential companies. The goal of this joint venture is to contribute to the development of regenerative medicine in Taiwan. Hitachi will contribute to maintaining people's health and improving QoL through the advancement of regenerative medicine, and at the same time promote Collaborative Creation with partners throughout the world to accelerate open innovation and contribute to increasing social value, environmental value, and economic value for customer companies.